Please assess the completion status of the following clinical trial:

Trial Title: Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female age 18 or older~* Willing to remove a palpable subdermal Implanon/ Nexplanon CI~* Willing and able to give written informed consent for participation in the investigation~* Willing to provide follow-up information according to the Clinical Investigators brochure~Exclusion Criteria:~* Known allergy to local anaesthetic (lidocaine/lignocaine) or disinfectant (chlorhexidine).~* Active skin lesion over the CI.~* The Investigator considers the subject unlikely to comply with investigational procedures, restrictions and requirements.~* Any contraindication for removal of the PI, as judged by the Investigator.~* Any disorders or medications that might affect coagulation, as judged by the Investigator.~* Any conditions suspected to affect healing or increase risk of infection (e.g. keloid tendency, diabetes or any upper arm dermatological condition that may affect upper arm healing)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- RemovAid arm (Type: EXPERIMENTAL): RemovAid arm -~All subjects have their implant removed by the RemovAid device

Based on this trial design, predict the completion outcome and termination type (if applicable).